Markets

Drugmaker AstraZeneca profit jumps as it expands in US

  • Profit after tax stood at $2.53 billion in the three months to the end of September
Published November 6, 2025 Updated November 6, 2025 12:52pm
By

LONDON: British pharmaceutical giant AstraZeneca on Thursday said its net profit jumped 77 percent in the third quarter as the group expands its operations in the United States.

Profit after tax stood at $2.53 billion in the three months to the end of September, up from $1.43 billion one year earlier, AstraZeneca said in a statement.